Literature DB >> 19537430

Why do individuals agree to enrol in clinical trials? A qualitative study of health research participation in Blantyre, Malawi.

Joseph Mfutso-Bengo1, Paul Ndebele, Vincent Jumbe, Matilda Mkunthi, Francis Masiye, Sassy Molyneux, Malcolm Molyneux.   

Abstract

Current literature suggests that therapeutic misconception a belief by participants in a clinical trial that they are in fact simply being given clinical care is common, especially among illiterate populations in developing countries. Therapeutic misconception reects problems in informed consent, as people agree to participate in clinical trials without being aware that the trial procedures and test products may not in fact benet them. In this study of Malawian adults who had participated in research projects of various kinds during the preceding years, we found that the majority participated in research for the sake of obtaining better quality treatment made available through the clinical trials as ancillary care. Their consent to participate was not due to a belief that the actual procedures of the trial would directly benet their health. Respondents indicated that, government hospitals being crowded and commonly lacking drugs, they agreed to take part in research projects in the hope of obtaining access to ancillary care provided by clinical trials. We conclude that in this environment, possibly owing to inadequacy of routine health services, people make rational decisions to participate in research. We question whether the term therapeutic misconception accurately describes participants motivation under conditions of limited resources. We also discuss the relevance of these ndings for understanding undue inducement in clinical trials.

Entities:  

Mesh:

Year:  2008        PMID: 19537430      PMCID: PMC3345665          DOI: 10.4314/mmj.v20i2.10898

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  17 in total

1.  Clarifying the ethics of clinical research: a path toward avoiding the therapeutic misconception.

Authors:  Paul S Appelbaum
Journal:  Am J Bioeth       Date:  2002       Impact factor: 11.229

2.  What makes placebo-controlled trials unethical?

Authors:  Franklin G Miller; Howard Brody
Journal:  Am J Bioeth       Date:  2002       Impact factor: 11.229

3.  The clinician-investigator: unavoidable but manageable tension.

Authors:  Howard Brody; Franklin G Miller
Journal:  Kennedy Inst Ethics J       Date:  2003-12

4.  False hopes and best data: consent to research and the therapeutic misconception.

Authors:  P S Appelbaum; L H Roth; C W Lidz; P Benson; W Winslade
Journal:  Hastings Cent Rep       Date:  1987-04       Impact factor: 2.683

5.  The therapeutic misconception: informed consent in psychiatric research.

Authors:  P S Appelbaum; L H Roth; C Lidz
Journal:  Int J Law Psychiatry       Date:  1982

6.  The continuing unethical use of placebo controls.

Authors:  K J Rothman; K B Michels
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

7.  Patient comprehension and reaction to participating in a double-blind randomized clinical trial (ISIS-4) in acute myocardial infarction.

Authors:  R Yuval; D A Halon; A Merdler; N Khader; B Karkabi; K Uziel; B S Lewis
Journal:  Arch Intern Med       Date:  2000-04-24

8.  Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial.

Authors:  K Featherstone; J L Donovan
Journal:  BMJ       Date:  1998-10-31

9.  Understanding of informed consent in a low-income setting: three case studies from the Kenyan Coast.

Authors:  C S Molyneux; N Peshu; K Marsh
Journal:  Soc Sci Med       Date:  2004-12       Impact factor: 4.634

10.  Randomisation in trials: do potential trial participants understand it and find it acceptable?

Authors:  C Kerr; E Robinson; A Stevens; D Braunholtz; S Edwards; R Lilford
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

View more
  27 in total

1.  Tailoring information provision and consent processes to research contexts: the value of rapid assessments.

Authors:  Susan Bull; Bobbie Farsides; Fasil Tekola Ayele
Journal:  J Empir Res Hum Res Ethics       Date:  2012-02       Impact factor: 1.742

2.  Participation of Ghanaian pregnant women in an antimalarial drug trial: willingness, experiences and perceptions.

Authors:  Joseph Osarfo; Rose O Adjei; Pascal Magnussen; Harry K Tagbor
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-06-02       Impact factor: 2.184

3.  Understanding of research: a Sri Lankan perspective.

Authors:  Athula Sumathipala; Sisira Siribaddana; Suwin Hewage; Manura Lekamwattage; Manjula Athukorale; Chesmal Siriwardhana; Kumudu Munasinghe; Kethakie Sumathipala; Joanna Murray; Martin Prince
Journal:  BMC Med Ethics       Date:  2010-04-27       Impact factor: 2.652

4.  Ethical challenges in integrating patient-care with clinical research in a resource-limited setting: perspectives from Papua New Guinea.

Authors:  Moses Laman; William Pomat; Peter Siba; Inoni Betuela
Journal:  BMC Med Ethics       Date:  2013-07-26       Impact factor: 2.652

5.  Randomized controlled trials of malaria intervention trials in Africa, 1948 to 2007: a descriptive analysis.

Authors:  Vittoria Lutje; Annette Gerritsen; Nandi Siegfried
Journal:  Malar J       Date:  2011-03-15       Impact factor: 2.979

6.  "When they see us, it's like they have seen the benefits!": experiences of study benefits negotiations in community-based studies on the Kenyan Coast.

Authors:  Dorcas M Kamuya; Vicki Marsh; Patricia Njuguna; Patrick Munywoki; Michael Parker; Sassy Molyneux
Journal:  BMC Med Ethics       Date:  2014-12-24       Impact factor: 2.652

7.  "The one who chases you away does not tell you go": silent refusals and complex power relations in research consent processes in Coastal Kenya.

Authors:  Dorcas M Kamuya; Sally J Theobald; Vicki Marsh; Michael Parker; Wenzel P Geissler; Sassy C Molyneux
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

Review 8.  Sharing the Knowledge: Sharing Aggregate Genomic Findings with Research Participants in Developing Countries.

Authors:  Angeliki Kerasidou
Journal:  Dev World Bioeth       Date:  2014-10-08       Impact factor: 2.294

9.  Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability.

Authors:  Lucy A Smith; Caroline Jones; Rose O Adjei; Gifty D Antwi; Nana A Afrah; Brian Greenwood; Daniel Chandramohan; Harry Tagbor; Jayne Webster
Journal:  Malar J       Date:  2010-01-14       Impact factor: 2.979

10.  "I understood…but some parts were confusing and hard to grasp": Patients' perception of informed consent forms and clinical trials in Eldoret, Kenya.

Authors:  Violet Naanyu; Fatma F Some; Abraham M Siika
Journal:  Perspect Clin Res       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.